ClinicalTrials.Veeva

Menu
C

Centro Reumatologico de Caguas | Caguas, PR

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cenerimod
Guselkumab
Nerandomilast
Ixekizumab
Obexelimab
ESK-001

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 7 total trials

A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus (OPUS-2)

The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematous in adult patients with moderate to sever...

Enrolling
Lupus Erythematosus, Systemic
Drug: Cenerimod
Drug: Placebo

The goal of this clinical trial is to learn if ESK-001 works to treat moderate to severe plaque psoriasis. The main questions it aims to answer are:*...

Enrolling
Plaque Psoriasis
Drug: ESK-001
Drug: Placebo

This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).

Enrolling
Systemic Lupus Erythematosus
Drug: Placebo
Drug: Obexelimab

Adults 18 years of age and older or above legal age with lung fibrosis related to systemic autoimmune rheumatic disease can participate in this study...

Begins enrollment in 1 month
Interstitial Lung Diseases
Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Drug: Nerandomilast
Drug: Placebo matching nerandomilast

Trial sponsors

Idorsia Pharmaceuticals logo
A
Boehringer Ingelheim logo
Lilly logo
Z
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems